Appointment booking for Dr. Anuradha Rameneni, MD is currently not available.Dr. Anuradha Rameneni, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Anuradha Rameneni, MD (she/her) is a Internist in Haverhill, MA with over 18 years of experience. What is your opinion of Dr. Anuradha Rameneni, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Anuradha Rameneni, MD has received over $1,880 which includes payments from the following companies:
$450.81 from AstraZeneca Pharmaceuticals LP
$428.00 from Novo Nordisk Inc
$148.91 from Merck Sharp & Dohme Corporation
$120.34 from Boehringer Ingelheim Pharmaceuticals, Inc.
$116.83 from Janssen Pharmaceuticals, Inc
$113.41 from FOREST PHARMACEUTICALS, INC.
$106.06 from GlaxoSmithKline, LLC.
$60.58 from Astellas Pharma US Inc
$56.36 from UCB, Inc.
$54.94 from AbbVie, Inc.
$49.87 from Actavis Pharma Inc
$49.01 from sanofi-aventis U.S. LLC
$31.33 from Valeritas, Inc.
$25.05 from Pfizer Inc.
$23.47 from Sunovion Pharmaceuticals Inc.
$20.54 from Takeda Pharmaceuticals America, Inc.
$14.32 from Boston Scientific Corporation
$10.71 from Eisai Inc.
Payments received by Dr. Anuradha Rameneni, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!